S Suissa, P Ernst, JF Boivin, RI Horwitz, B Habbick, D Cockroft, L Blais, M McNutt, AS Buist and WO Spitzer
Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec.

The association between the use of inhaled beta-agonists and the risk of death and near-death from asthma has previously been reported. It was based on a nested case-control study of 129 cases and 655 control subjects selected from a cohort of 12,301 users of asthma drugs followed during the period 1980 through 1987. In this paper we examine the question of asthma and non-asthma mortality using data from the entire cohort of 12,301 asthmatics. There were 46 asthma and 134 non- asthma deaths in this cohort, for which there were 47,842 person-years of follow-up. The overall rate of asthma death was 9.6 per 10,000 asthmatics per year. This rate varied significantly according to the use of fenoterol, albuterol, or oral corticosteroids in the prior 12 months and the number of asthma hospitalizations in the prior 2 years. The rate decreased significantly, by 0.6 asthma deaths per 10,000 asthmatics per year over the study period, after controlling for the effect of the four other risk factors. It also increased significantly with the use of all beta-agonists, and more so for fenoterol than for albuterol, although this difference was partly explained by the dose inequivalence of the two drugs. Change-point dose-response curves showed that the risk of asthma death began to escalate drastically at about 1.4 canisters (of 20,000 micrograms each) per month of inhaled beta-agonist, the recommended limit. For non-asthma death, the overall rate of 28 deaths per 10,000 asthmatics per year was not related to the use of inhaled beta-agonists.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. E. Erickson, C. Iribarren, I. V. Tolstykh, P. D. Blanc, and M. D. Eisner Effect of Race on Asthma Management and Outcomes in a Large, Integrated Managed Care Organization Arch Intern Med, September 24, 2007; 167(17): 1846 - 1852. [Abstract] [Full Text] [PDF]

				C. S. Calfee, P. P. Katz, E. H. Yelin, C. Iribarren, and M. D. Eisner The influence of perceived control of asthma on health outcomes. Chest, November 1, 2006; 130(5): 1312 - 1318. [Abstract] [Full Text] [PDF]

				D. M. Williams Considerations in the long-term management of asthma in ambulatory patients Am. J. Health Syst. Pharm., May 15, 2006; 63(10_Supplement_3): S14 - S21. [Abstract] [Full Text] [PDF]

				A. Senthilselvan, J. A. Lawson, D. C. Rennie, and J. A. Dosman Regular Use of Corticosteroids and Low Use of Short-Acting {beta}2-Agonists Can Reduce Asthma Hospitalization Chest, April 1, 2005; 127(4): 1242 - 1251. [Abstract] [Full Text] [PDF]

				P. M. O'Byrne, H. Bisgaard, P. P. Godard, M. Pistolesi, M. Palmqvist, Y. Zhu, T. Ekstrom, and E. D. Bateman Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 129 - 136. [Abstract] [Full Text] [PDF]

				A. A Fisher, M. W Davis, and D. A McGill Acute Myocardial Infarction Associated with Albuterol Ann. Pharmacother., December 1, 2004; 38(12): 2045 - 2049. [Abstract] [Full Text] [PDF]

				G. E. D'Alonzo Jr. Levalbuterol in the Treatment of Patients With Asthma and Chronic Obstructive Lung Disease J Am Osteopath Assoc, July 1, 2004; 104(7): 288 - 293. [Abstract] [Full Text] [PDF]

				Z. Callaerts-Vegh, K. L. J. Evans, N. Dudekula, D. Cuba, B. J. Knoll, P. F. K. Callaerts, H. Giles, F. R. Shardonofsky, and R. A. Bond Effects of acute and chronic administration of {beta}-adrenoceptor ligands on airway function in a murine model of asthma PNAS, April 6, 2004; 101(14): 4948 - 4953. [Abstract] [Full Text] [PDF]

				R H Green, C E Brightling, I D Pavord, and A J Wardlaw Management of asthma in adults: current therapy and future directions Postgrad. Med. J., May 1, 2003; 79(931): 259 - 267. [Abstract] [Full Text] [PDF]

				L. D. Lynd, D. P. Guh, P. D. Pare, and A. H. Anis Patterns of Inhaled Asthma Medication Use: A 3-Year Longitudinal Analysis of Prescription Claims Data From British Columbia, Canada Chest, December 1, 2002; 122(6): 1973 - 1981. [Abstract] [Full Text] [PDF]

				Y. Golan, A. Onn, Y. Villa, Y. Avidor, S. Kivity, S. A. Berger, I. Shapira, Y. Levo, and M. Giladi Asthma in Adventure Travelers: A Prospective Study Evaluating the Occurrence and Risk Factors for Acute Exacerbations Arch Intern Med, November 25, 2002; 162(21): 2421 - 2426. [Abstract] [Full Text] [PDF]

				S Suissa, P Ernst, and A Kezouh Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma Thorax, October 1, 2002; 57(10): 880 - 884. [Abstract] [Full Text] [PDF]

				S F Lanes, L A Garcia Rodriguez, and C Huerta Respiratory medications and risk of asthma death Thorax, August 1, 2002; 57(8): 683 - 686. [Abstract] [Full Text] [PDF]

				J Burggraaf, R G J Westendorp, J C C M i.`t Veen, R C Schoemaker, P J Sterk, A F Cohen, and G J Blauw Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients Thorax, July 1, 2001; 56(7): 567 - 569. [Abstract] [Full Text] [PDF]

				S. V. Bourdet and D. Williams Management Considerations for Chronic Asthma Journal of Pharmacy Practice, April 1, 2001; 14(2): 108 - 125. [Abstract] [PDF]

				M.D. Eisner, T.A. Lieu, F. Chi, A.M. Capra, G.R. Mendoza, J.V. Selby, and P.D. Blanc Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma Eur. Respir. J., February 1, 2001; 17(2): 233 - 240. [Abstract] [Full Text] [PDF]

				S. Suissa, P. Ernst, S. Benayoun, M. Baltzan, and B. Cai Low-Dose Inhaled Corticosteroids and the Prevention of Death from Asthma N. Engl. J. Med., August 3, 2000; 343(5): 332 - 336. [Abstract] [Full Text] [PDF]

				J. C. W. Mak, A. F. Roffel, T. Katsunuma, C. R. S. Elzinga, J. Zaagsma, and P. J. Barnes Up-Regulation of Airway Smooth Muscle Histamine H1 Receptor mRNA, Protein, and Function by beta 2-Adrenoceptor Activation Mol. Pharmacol., May 1, 2000; 57(5): 857 - 864. [Abstract] [Full Text]

				D. D Sin and J. V Tu Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease Thorax, March 1, 2000; 55(3): 194 - 197. [Abstract] [Full Text]

				G. B. Diette, A. W. Wu, E. A. Skinner, L. Markson, R. D. Clark, R. C. McDonald, J. P. Healy Jr, M. Huber, and D. M. Steinwachs Treatment Patterns Among Adult Patients With Asthma: Factors Associated With Overuse of Inhaled {beta}-Agonists and Underuse of Inhaled Corticosteroids Arch Intern Med, December 13, 1999; 159(22): 2697 - 2704. [Abstract] [Full Text] [PDF]

				{beta}2-Agonists Can. Med. Assoc. J., November 1, 1999; 161(90111): s28 - 31. [Full Text]

				T. Katsunuma, A. F. Roffel, C. R. S. Elzinga, J. Zaagsma, P. J. Barnes, and J. C. W. Mak beta 2-Adrenoceptor Agonist-Induced Upregulation of Tachykinin NK2 Receptor Expression and Function in Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 409 - 417. [Abstract] [Full Text]

				P. Chervinsky, P. Goldberg, S. Galant, Y. Wang, T. Arledge, M. B. Welch, and E. Stahl Long-term Cardiovascular Safety of Salmeterol Powder Pharmacotherapy in Adolescent and Adult Patients With Chronic Persistent Asthma: A Randomized Clinical Trial Chest, March 1, 1999; 115(3): 642 - 648. [Abstract] [Full Text] [PDF]

				P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]

				S. Mitra, M. Ugur, O. Ugur, H. M. Goodman, J. R. McCullough, and H. Yamaguchi (S)-Albuterol Increases Intracellular Free Calcium by Muscarinic Receptor Activation and a Phospholipase C-Dependent Mechanism in Airway Smooth Muscle Mol. Pharmacol., March 1, 1998; 53(3): 347 - 354. [Abstract] [Full Text]

				S. Suissa, P. Ernst, D. Zahger, J. M. Drazen, E. Israel, and The National Heart, Lung, and Blood Institute's As Albuterol in Mild Asthma N. Engl. J. Med., March 6, 1997; 336(10): 729 - 730. [Full Text]

				Using {beta}2-stimulants in asthma DTB, January 1, 1997; 35(1): 1 - 4. [Abstract] [Full Text] [PDF]

				C. P. NIELSON and N. E. HADJOKAS Beta-Adrenoceptor Agonists Block Corticosteroid Inhibition in Eosinophils Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 184 - 191. [Abstract] [Full Text]

				K S Joseph, L. Blais, P. Ernst, and S. Suissa Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers BMJ, January 13, 1996; 312(7023): 79 - 81. [Abstract] [Full Text]

				H. S. Nelson {beta}-Adrenergic Bronchodilators N. Engl. J. Med., August 24, 1995; 333(8): 499 - 507. [Full Text] [PDF]

				MORE ON BETA AGONISTS AND ASTHMA MORTALITY Journal Watch (General), March 29, 1994; 1994(329): 3 - 3. [Full Text]